Clinical Trial

Hereditary Hemorrhagic Telangiectasia (HHT) Outcomes

Study Description

Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry

The goal of this study is to better understand HHT, the symptoms and complications it causes ("outcomes") and how the disease impacts people's lives. The investigators are aiming to recruit and gather information together in the Registry from 1,000 HHT patients from four HHT Centres of Excellence in North America. The Investigators will collect long-term information about the people in the Registry, allowing the investigators to understand how the disease changes over time, and what factors can influence those changes. Ultimately, this should help improve treatments for the disease.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Registry and Saliva sample

Non-interventional registry with saliva sample collected for DNA analysis

Additional Information

Official Study Title

Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry

Clinical Trial ID

NCT04150822

ParticipAid ID

av2Vra